These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 38343922)

  • 1. The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2.
    Hu Y; Liu L; Zhang S; Su S; Liang X
    ACS Omega; 2024 Feb; 9(5):5175-5192. PubMed ID: 38343922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the use of biomaterials, nanotechnology, and stem cells for detection and treatment of COVID-19: towards a framework to address future global pandemics.
    Ghaffari M; Mollazadeh-Bajestani M; Moztarzadeh F; Uludağ H; Hardy JG; Mozafari M
    Emergent Mater; 2021; 4(1):19-34. PubMed ID: 33426467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can nanotechnology help to combat COVID-19? Opportunities and urgent need.
    Campos EVR; Pereira AES; de Oliveira JL; Carvalho LB; Guilger-Casagrande M; de Lima R; Fraceto LF
    J Nanobiotechnology; 2020 Sep; 18(1):125. PubMed ID: 32891146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing biomaterials for therapeutic strategies against COVID-19.
    Colombani T; Rogers ZJ; Eggermont LJ; Bencherif SA
    Emergent Mater; 2021; 4(1):9-18. PubMed ID: 33842840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks.
    Cao M; Su X; Jiang S
    Stem Cell Reports; 2021 Mar; 16(3):398-411. PubMed ID: 33691145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomaterials-based formulations and surfaces to combat viral infectious diseases.
    Kumari S; Chatterjee K
    APL Bioeng; 2021 Mar; 5(1):011503. PubMed ID: 33598595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biomaterials viewpoint for the 2020 SARS-CoV-2 vaccine development.
    Jatoi I; Fan J
    Biomater Transl; 2021; 2(1):30-42. PubMed ID: 35837251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Transmission, prevention, and potential therapeutic opportunities.
    Lotfi M; Hamblin MR; Rezaei N
    Clin Chim Acta; 2020 Sep; 508():254-266. PubMed ID: 32474009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models for studying coronavirus infections and developing antiviral agents and vaccines.
    Lin Q; Lu C; Hong Y; Li R; Chen J; Chen W; Chen J
    Antiviral Res; 2022 Jul; 203():105345. PubMed ID: 35605699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.
    Dashraath P; Wong JLJ; Lim MXK; Lim LM; Li S; Biswas A; Choolani M; Mattar C; Su LL
    Am J Obstet Gynecol; 2020 Jun; 222(6):521-531. PubMed ID: 32217113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Based Biomaterials for Coronavirus Disease 2019 Prevention and Therapy.
    Li C; Wang C; Xie HY; Huang L
    Adv Healthc Mater; 2023 Jul; 12(18):e2300404. PubMed ID: 36977465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19).
    Ertas YN; Mahmoodi M; Shahabipour F; Jahed V; Diltemiz SE; Tutar R; Ashammakhi N
    Emergent Mater; 2021; 4(1):35-55. PubMed ID: 33748672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of microfluidic technologies on COVID-19 diagnosis and drug discovery.
    Lin Z; Zou Z; Pu Z; Wu M; Zhang Y
    Acta Pharm Sin B; 2023 Feb; 13(7):2877-96. PubMed ID: 36855672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.